Cargando…
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study
INTRODUCTION: Previous studies have found differences in the communication of safety issues among medicines regulatory agencies. OBJECTIVES: To explore (1) to what extent regulators’ opinions regarding the need to communicate safety issues related to sodium-glucose cotransporter-2 (SGLT2) inhibitors...
Autores principales: | Roldan Munoz, Sonia, Postmus, Douwe, de Vries, Sieta T., Gross-Martirosyan, Liana, Bahri, Priya, Hillege, Hans, Mol, Peter G. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988744/ https://www.ncbi.nlm.nih.gov/pubmed/36790560 http://dx.doi.org/10.1007/s40264-022-01270-4 |
Ejemplares similares
-
Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study
por: Roldan Munoz, Sonia, et al.
Publicado: (2021) -
A simulated maximum likelihood procedure for analyzing imprecise trade‐off thresholds between the benefits and harms of medicines
por: Postmus, Douwe, et al.
Publicado: (2022) -
Differences in medication beliefs between pregnant women using medication, or not, for chronic diseases: a cross-sectional, multinational, web-based study
por: Roldan Munoz, Sonia, et al.
Publicado: (2020) -
Website Visitors Asking Questions Online to Lung Cancer Specialists: What Do They Want To Know?
por: Schook, Romane M, et al.
Publicado: (2013) -
Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
por: Cao, Qi, et al.
Publicado: (2018)